Evidence map›Paper›PMID 38560180›Full record

ArticleHeliyon2024

Prognostic effect of DNA methylation of

Jungang Ma, Zhuo Chen, Shuixia Liu, Chuan Chen, Wei Guan, Mingying Geng, He Xiao, Bijing Mao, Bin Wang

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Heliyon, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.7field-weighted citation impact, top 32% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 3 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 4 institutions in 1 country.

Jungang MaDepartment of Oncology, Daping Hospital, Army Medical University, Chongqing, 400042, China.
Zhuo ChenDepartment of Oncology, Daping Hospital, Army Medical University, Chongqing, 400042, China.
Shuixia LiuDepartment of Ophthalmology, Daping Hospital, Army Medical University, Chongqing, 400042, China.
Chuan ChenDepartment of Oncology, Daping Hospital, Army Medical University, Chongqing, 400042, China.
Wei GuanDepartment of Oncology, Daping Hospital, Army Medical University, Chongqing, 400042, China.
Mingying GengDepartment of Oncology, Daping Hospital, Army Medical University, Chongqing, 400042, China.
He XiaoDepartment of Oncology, Daping Hospital, Army Medical University, Chongqing, 400042, China.
Bijing MaoDepartment of Oncology, The Third Affiliated Hospital of Chongqing Medical University, Chongqing, 401120, China.
Bin WangDepartment of Oncology, The Seventh People's Hospital of Chongqing (Affiliated Central Hospital of Chongqing University of Technology), Chongqing, 400054, China.
Army Medical University · CNDaping Hospital · CNChongqing Medical University · CNChongqing University of Technology · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: This study aims to develop a prognostic model for overall survival based on potential methylation sites within B-cell translocation gene 2 ( Methods: This is a retrospective study. The beta values of nine CpG sites and RSEM normalized count values of Results: The beta value of cg01798157 was significantly negatively associated with the mRNA expression of Conclusions: The methylation level of cg01798157 in

Indexed as

B-cell translocation gene 2DNA methylationHepatocellular carcinomaPrognosis

Identifiers

PMID38560180
PMCPMC10979207
OpenAlexW4393176178

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.